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Immunometabolism, the study of the relationship between bioenergetic pathways 
and specific functions of immune cells, has recently gained increasing appreciation. 
In response to infection, activation of the host innate and adaptive immune cells is 
accompanied by a switch in the bioenergetic pathway from oxidative phosphorylation to 
glycolysis, a metabolic remodeling known as the Warburg effect, which is required for the 
production of antimicrobial and pro-inflammatory effector molecules. In this review, we 
summarize the current understanding of the Warburg effect and discuss its association 
with the expression of host immune responses in tuberculosis (TB), an infectious disease 
caused by Mycobacterium tuberculosis (Mtb). We also discuss potential mechanisms 
underlying the Warburg effect with a focus on the expression and regulation of hypox-
ia-inducible factor 1 alpha (HIF-1α), the regulatory subunit of HIF-1, a major transcription 
regulator involved in cellular stress adaptation processes, including energy metabolism 
and antimicrobial responses. We also propose a novel hypothesis that Mtb perturbs the 
Warburg effect of immune cells to facilitate its survival and persistence in the host. A 
better understanding of the dynamics of metabolic states of immune cells and their spe-
cific functions during TB pathogenesis can lead to the development of immunotherapies 
capable of promoting Mtb clearance and reducing Mtb persistence and the emergence 
of drug resistant strains.
Keywords: the warburg effect, hypoxia-inducible factor 1 alpha, metabolism, tuberculosis, granuloma, immune 
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TUBeRCULOSiS
Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis (Mtb), has 
become the top killer disease alongside HIV/AIDS, responsible for 1.5 million deaths in 2014 
(1). In the infected host, the outcome following Mtb infection is determined by both host- and 
pathogen-derived factors and by their interactions (2, 3). One of the pathological hallmarks of TB 
is the formation of the granuloma, an orderly aggregation of host immune cells around the infected 
macrophage(s), because of complex host–pathogen interactions at the site of infection (4, 5). A key 
factor for the success of Mtb as a pathogen is its ability to survive and persist in host cells within the 
granulomas for long periods of time and to exacerbate pathological progression, which ultimately 
results in bacillary spread within and between the hosts (4). As a focus of the disease, mycobacterial 
granulomas have been the subject of intense studies mainly aimed at understanding the mechanisms 
of their formation, function, maintenance, and evolution. Gaining a better understanding of these 
processes will not only shed light on the host and pathogen factors involved in TB pathogenesis but 
also facilitate the development of novel pathogen- and/or host-directed therapeutic strategies to 
eliminate TB.
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GRANULOMA FORMATiON AND 
MAiNTeNANCe
Tuberculoma or granuloma during Mtb infection is formed by 
an orchestrated series of events involving host chemokines and 
cytokines that coordinate the recruitment of immune cells from 
circulation and their accumulation at the infection foci. During 
initial stages of the granuloma formation, chemokines and 
cytokines produced mainly by the infected alveolar macrophages 
and dendritic cells (DCs) bring about a focal recruitment and 
accumulation of mononuclear cells (4, 6). Although fully acti-
vated phagocytes are capable of killing Mtb, the pathogen can 
survive and proliferate in the phagocytes by inhibiting their 
innate immune functions (7–9), for instance, by interfering 
with the phagosome–lysosome maturation and acidification 
pathways (10) and by inducing immune suppressive functions of 
the infected host cells, e.g., by elevating IL-10 production (11). 
Modulation of innate immune cell functions by Mtb can also 
lead to altered T cell-mediated immune functions (9, 12), which 
are an important factor responsible for the delayed initiation 
and activation of adaptive immunity during Mtb infection in the 
lungs (13–15).
With the accumulation of activated T lymphocytes, the 
granuloma becomes a fully organized structure, containing a 
central area of Mtb-infected macrophages surrounded by freshly 
recruited, non-infected phagocytes and lymphocytes. In the 
vicinity of this highly cellular “solid” granuloma, macrophages 
are activated toward a M1 phenotype by the cytokines and anti-
microbial effector molecules produced by the cells of innate and 
adaptive immunity, which ultimately curtails intracellular bacte-
rial growth and drives the infection into latent/persistent stage 
(5, 16, 17). When the infection progresses toward active disease, 
Mtb alters the macrophage polarization toward a M2 phenotype, 
which is associated with anti-inflammatory properties and ele-
vated lipid metabolism that contributes to the formation of foamy 
macrophages (18). This process facilitates necrosis of immune 
cells at the center of the granuloma, enhancing the possibility of 
Mtb dissemination. Although granulomas have been traditionally 
regarded as cellular structures beneficial to the host that seal off 
the infection and focus the immune response to a limited area, 
recent reports indicate that tuberculous granulomas also act as 
survival niches for Mtb, and that the host–pathogen interactions 
in the granulomas play key role in the expansion and dissemi-
nation of infection (4, 19). Thus, formation, maintenance, and 
evolution of granulomas are now regarded as a balance between 
antimicrobial effectors of host immune cells and the ability of Mtb 
to withstand these bactericidal factors and cause disease.
The central role of host–pathogen interactions in TB progres-
sion is supported by multiple reports, including recent findings 
that the ESAT-6/CFP-10 complex, a major virulence factor of 
pathogenic Mtb, plays critical roles in driving the granuloma 
evolution in a zebrafish infection model (20). This notion is also 
supported by the diminished and/or altered pathophysiology 
caused by some persistent phenotype mutants of Mtb (such 
as sigE and sigH deletion mutants), which are associated with 
decreased recruitment of T cells or adaptive immunity but are 
independent of in  vivo bacterial growth (21, 22). Modulation 
of granuloma formation and maintenance by Mtb is further 
underscored by the differential outcome of infection by two 
clinical Mtb strains of different virulence (23, 24). In the rabbit 
model of TB that mimics several aspects of human TB, including 
the formation of well-differentiated granulomas, ranging from 
necrotic, caseating, and cavitating to healing lesions, pulmonary 
infection by a hypervirulent Mtb strain HN878 results in active 
disease in the lungs of rabbit, marked with high bacillary load 
and destructive disease pathology (24). In contrast, infection by 
a hyper-immunogenic Mtb CDC1551 strain cannot sustain the 
high bacterial numbers after protracted initial growth, and the 
infection establishes a latent stage with time, characterized by 
undetectable level of bacillary load and absence of lung pathol-
ogy; however, these latently infected animals can reactivate 
bacillary growth and disease pathology upon immune suppres-
sion treatment (23,  25). Understanding various cellular and 
molecular components of granuloma formation, development, 
and evolution and their roles in protecting the host will thus be 
of paramount significance for the development of preventive and 
therapeutic strategies against TB.
THe wARBURG eFFeCT AND iMMUNe 
CeLL FUNCTiONS
Recently, there has been an increasing appreciation of the 
importance of the relationship between the bioenergetic path-
ways and immune cell functions. Thus, immunometabolism has 
emerged as a new field of investigation focusing on understand-
ing how and why immune cells commit to a particular metabolic 
fate to support or direct functional changes. Unlike other cells, 
immune cells are required to stay in a relatively quiescent state 
under normal physiological conditions and to activate and 
mount rapid response and effector functions upon infection or 
under pathological conditions. Recent reports indicate that dif-
ferential metabolic signatures are essential for specific effector 
functions of cells of both innate and adaptive immune systems 
(26, 27). For example, as an essential component of innate 
immunity, the macrophage undergoes reprogramming to two 
predominant functional phenotypes: the classically activated 
(M1) and the alternatively activated (M2) states (28, 29). The 
M1 macrophages activated in response to interferon-γ (IFN-γ) 
and toll-like receptor (TLR) ligands, such as lipopolysaccharide 
(LPS), generate pro-inflammatory cytokines that potentiate the 
activation and differentiation of inflammatory, Th1 type adap-
tive immune cells (28). Metabolically, M1 cells display enhanced 
glycolysis and decreased oxygen consumption (30, 31). A 
comprehensive metabolic map of LPS-activated macrophages 
shows upregulation of glycolytic genes and downregulation 
of mitochondrial genes, which correlates directly with the 
profiles of altered metabolites (32). Perturbation of glycolysis, 
for instance, by blocking the monocarboxylate transporter 4 
(MCT4) (a major lactate secretion transporter) in LPS-activated 
macrophages, diminishes nitric oxide (NO) production and the 
expression of pro-inflammatory cytokines (33). In contrast, the 
M2 macrophages formed in response to Th2 cytokines, such as 
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IL-4 and IL-13, are characterized by higher levels of scavenger 
receptors and anti-inflammatory cytokines (34), and these cells’ 
metabolic profiles are similar to those of non-polarized, resting 
macrophages, in which mitochondrial fatty acid oxidation and 
oxidative metabolism are the major carbon and energy sources 
(30). Similarly, metabolic reprogramming of DCs is also associ-
ated with their activation and functions (35). In immunogenic 
DCs, a metabolic switch characterized by increased glyco-
lysis and concurrent decrease in oxidative phosphorylation in 
response to TLR stimulation was reported to be essential for 
their effective maturation and functions (36–39). However, in 
tolerogenic DCs, increased expression of genes involved in the 
mitochondrial oxidative phosphorylation (40, 41) is consistent 
with their functional phenotype marked with maturation resist-
ance and increased level of immunoregulatory factors (42, 43), 
which are important for regulatory T cell response. Likewise, 
upon activation, effector T cells also reprogram their metabo-
lism from an oxidative metabolism to a highly glycolytic and 
glutamine-dependent metabolic program, and this metabolic 
transition enables cell growth, proliferation, differentiation, and 
secretion of effector molecules, whereas oxidative phosphoryla-
tion is the dominant energy source in naive and regulatory T 
cells (44–47). Fatty acid oxidation was shown to be crucial 
for the development and survival of CD8+ memory and CD4+ 
regulatory T cells (47–50).
Enhanced glycolysis is generally accompanied with a 
concurrent increase of the pentose phosphate pathway (PPP) 
that provides the NADPH and ribose phosphate in activated 
immune cells (32, 36). This metabolic switch is reminiscent of 
the Warburg effect in cancer cells that predominantly utilize 
aerobic glycolysis instead of oxidative phosphorylation in mito-
chondria as the main route of ATP generation and recycling of 
NADH to NAD+ with the formation of lactate (51). Glycolysis 
not only produces ATP faster, albeit less efficiently, than oxida-
tive phosphorylation but also provides biosynthetic precursors 
needed for rapid cell growth, proliferation, and cellular biosyn-
thetic capacity (52). Thus, a shift to the Warburg effect supports 
a rapid and vigorous response during immune cell activation, 
such as activation of inflammatory response to infection, which 
involves not only rapid cell growth and proliferation but also the 
generation of pro-inflammatory cytokines and antimicrobial 
molecules, including reactive oxygen and nitrogen species (ROS 
and RNS).
The Warburg effect is regulated by the master transcription 
factor – hypoxia-inducible factor 1 (HIF-1) (53, 54). HIF-1 func-
tions as a heterodimer that comprised a highly regulated HIF-1α 
and constitutively expressed HIF-1β subunits (55). Identified for 
its role in hypoxia, HIF-1 also plays a regulatory role in response 
to a variety of molecular signals of infection and inflammation 
even under normoxic conditions (56, 57). HIF-1α is induced by 
pro-inflammatory cytokines, growth factors, and a broad range 
of infections (57–62), and its induction is a general component 
of the host response to infection (63). For example, HIF-1α is 
required for the pro-inflammatory Th17 cell differentiation (64), 
the activation and regulation of glycolytic capacity in myeloid 
cells (65), and for the release of pro-inflammatory cytokines, 
expression of co-stimulatory molecules, and induction of the 
Warburg effect enzymes in DCs (66).
Hypoxia-inducible factor 1 alpha expression is regulated 
at both transcriptional and posttranslational levels. Members 
of the nuclear factor-κB (NF-κB) family constitute a major 
signaling pathway closely associated with Hif-1a/HIF-1A 
expression (57, 63). Posttranslational regulation is mainly 
mediated through the stabilization of HIF-1α protein. Under 
normal physiological conditions, the HIF-1α level is kept low 
by proteasome-mediated degradation after hydroxylation by 
three oxygen-dependent prolyl hydrolases (PHDs) (67). A fac-
tor inhibiting HIF (FIH), an aspariginyl hydrolase, also inhibits 
the transactivation function of HIF-1α (68). The PHDs belong 
to an α-ketoglutarate (2-oxoglutarate)-dependent dioxygenase 
superfamily that uses O2 as a co-substrate to add a hydroxyl 
group to specific proline residues within the HIF-α oxygen-
dependent domains (67). Upon infection or during inflam-
mation, increased Hif-1a/HIF-1A expression and inhibition of 
PHDs and/or FIH activity lead to elevated levels of HIF-1α, 
which in turn positively regulates several cellular processes, 
including myeloid cell infiltration and activation and the induc-
tion of glycolytic isoenzymes and glucose transporters (65, 66). 
Tricarboxylic acid (TCA) cycle intermediates also contribute 
to the stabilization of HIF-1α by inhibiting the PHDs (69). In 
particular, increased levels of succinate from the TCA cycle were 
shown to serve as an inflammatory signal to induce IL-1β by the 
stabilization of HIF-1α through the direct inhibition of PHDs 
in LPS-treated macrophages (32). HIF-1α stabilization was also 
shown to depend on ROS (70).
THe wARBURG eFFeCT iN TB
The warburg effect in Murine  
Models of TB
We recently reported RNA-seq- and immunohistochemistry-
based evidence of the Warburg effect in immune cells during 
early stages of granuloma formation in a murine model of 
low-dose aerosol Mtb infection (71) (Figure  1). Specifically, 
we observed that in response to Mtb infection, host central 
metabolism was characterized by a coordinated upregula-
tion of genes encoding enzymes/isozymes reminiscent of 
the Warburg effect in cancer cells (53). These include genes 
encoding facilitative glucose transporters 1, 3, and 6 (GLUT1, 
3, and 6), glycolytic enzymes/isozymes including hexokinases 
(HK2 and 3), members of phosphofructokinase (PFK) family 1 
and 2, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
phosphoglycerate kinase 1 (PGK1), enolase 1 (ENO1), lactate 
dehydrogenase A (LDHA), and MCT4. Gene expression 
profiles were corroborated by increased protein expression 
of the representative Warburg effect enzymes and H+-ATPase 
in host immune cells, suggesting an enhanced glycolytic flux 
in infected mouse lungs (71). Furthermore, 1H NMR-based 
metabolomics profiling revealed increased accumulation of 
lactate, the product of glycolysis, in the lungs of Mtb-infected 
mice (72). Elevated glycolytic flux was also supported by our 
FiGURe 1 | intensity plot of transcripts encoding enzymes/proteins 
involved in the warburg effect and its regulation by HiF-1α-
associated mechanism in Mtb-infected mouse lungs. Shown are fold 
change in gene expression, derived from ratios of the normalized mRNA 
counts [fragments per kilobase of exon per million (FPKM) fragments 
mapped] at day 30 (D30) postinfection vs. D12 and at D30 vs. D0. WT 
C57BL/6 mice were infected with ~100 CFU of Mtb H37Rv via the respiratory 
route, and lung samples were harvested at specific points for RNA-seq. Data 
are derived from Shi et al. (71). Intensity plot was constructed using Partek 
Genomics Suite (PGS) ver 6.5. The color scale ranges from +3 (up; red) to 
−3 (down; blue). The genes are arranged according to their hierarchical 
position in the respective pathways.
recent finding of concurrent downregulation of pyruvate 
oxidation and oxidative phosphorylation in the mitochondria 
(71). We also observed a simultaneous upregulation of PPP in 
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mouse lungs, which is in agreement with the metabolic state of 
activated immune cells (27, 73). Our study also revealed that 
the Warburg effect is concurrent with increased levels of mRNA 
and protein of HIF-1α in macrophages and T cells, suggesting a 
possible role of HIF-1α in regulating the Warburg effect during 
Mtb infection (Figure 1).
Given that the Warburg effect in mouse lungs occurs in 
parallel with the expression of host adaptive immunity (71, 
74), our data suggest that the Warburg effect may constitute a 
bioenergetic requirement to mount effective host antimicrobial 
and immune responses to Mtb infection (74). This notion is 
in  line with the recent findings that stabilization of the host 
HIF-1α, both pharmacologically and genetically, at early stages 
of M. marinum infection in zebrafish, is associated with reduced 
bacterial burden in infected larvae, and that increasing the 
HIF-1α signaling enhances RNS levels in neutrophils (75). The 
importance of HIF-1α is also underscored by the observation 
that a mouse strain lacking HIF-1α displays impaired resistance 
against M. avium infection and premature emergence of granu-
loma necrosis (76).
To corroborate observations from infected mouse lungs, we 
analyzed the transcriptome data from murine bone marrow-
derived macrophages (MBDMs) infected by either of the two 
clinical Mtb strains, CDC1551 or HN878 (77). Given that these 
two clinical strains induce differential immune responses at the 
initial stage of the MBDM infection (77), a difference in the 
metabolic state of infected macrophages by these two strains 
was expected. Indeed, while a similar set of genes encoding the 
Warburg effect enzymes/isoenzymes and HIF-1α-associated 
signaling was induced in MBDMs infected by both strains 
(Table 1), we also noted a divergence in the glucose metabolism 
and glycolytic flux in the infected macrophages. In particular, 
while the early (6  h postinfection) upregulation of glucose 
transporter gene Glut6 was similar in MBDM infected by these 
two strains, a heightened induction of Pfkfb3, which encodes 
the 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 
(PFKFB3) of PFK-2 family, was observed in CDC1551-infected 
MBDMs (Table 1), similar to the results obtained from Mtb-
infected mouse lungs (71) (Figure  1). As PFKFB3 has the 
highest kinase/phosphatase activity ratio among the PFK-2 
members and its product fructose-2,6-diphosphate (F-2,6-BP) 
plays a key regulatory role for potentiating the glycolysis flux by 
relieving the inhibition of PFK-1 (78), a heightened induction 
of Pfkfb3 in CDC1551-infected MBDMs is expected to result 
in enhanced the glycolytic flux. Thus, the high glycolysis state 
in Mtb CDC1551-infected MBDMs may constitute the meta-
bolic basis for the robust early pro-inflammatory responses in 
these cells. Consistently, genes encoding inflammatory and 
antimicrobial effector molecules such as Il12b, Ccl8, Cxcl9, 
and Nos2 were highly upregulated in these macrophages 
(77). In contrast, a relatively low activation of the Warburg 
effect together with elevated glucose uptake observed in Mtb 
HN878-infected MBDMs may be associated with the induction 
of a dysregulated host cell lipid metabolism, which results in 
a less stressful intracellular environment for Mtb HN878, as 
described by Koo et al. (77).
TABLe 1 | Change in the transcripts encoding facilitative glucose transporters, glycolytic enzymes, monocarboxylate transporters (MCTs), subunits of 
H+ v-ATPase, HiF-1α, and factors associated with HiF-1α regulation in murine MBDMs.
Gene iD Symbol CDC1551 (6 h) HN878 (6 h) CDC1551 (24 h) HN878 (24 h)
Facilitative glucose transporters and glycolysis
10507594 Slc2a1 (Glut1) 4.33 4.15 1.83 2.50
10547641 Slc2a3 (Glut3) −2.44 −2.06 1.35 −1.08
10481164 Slc2a6 (Glut6) 12.37 11.89 2.04 2.51
10369541 Hk1 1.93 1.41 1.51 1.67
10545588 Hk2 3.11 2.52 2.49 2.52
10409376 Hk3 2.10 1.69 2.91 2.75
10562360 Gpi1 −1.75 −1.39 1.09 1.15
10370376 Pfkl 2.18 2.28 1.47 2.12
10426557 Pfkm −1.85 −1.65 −1.06 −1.04
10407481 Pfkp 2.36 1.68 −1.05 1.16
10602385 Pfkfb1 −1.22 −1.19 1.09 1.06
10357535 Pfkfb2 −3.17 −2.23 −1.05 −1.09
10480035 Pfkfb3 10.27 4.34 2.13 2.28
10589329 Pfkfb4 −3.03 −1.80 −1.09 −1.21
10568050 Aldoa −1.14 1.03 1.35 1.43
10379153 Aldoc −1.75 −2.04 −1.31 1.37
10547830 Tpi1 −1.28 −1.15 1.58 1.80
10601390 Pgk1 1.22 1.29 1.67 1.85
10450923 Pgk2 1.16 1.09 1.29 1.23
10473240 Eno1 −1.13 1.19 1.28 1.59
10547807 Eno2 2.20 3.77 3.75 3.96
10377938 Eno3 −1.19 −1.17 1.02 −1.02
10493382 Pklr 1.25 1.19 1.07 1.13
10585932 Pkm2 −1.08 1.05 1.54 1.64
10553301 Ldha 1.06 1.03 1.27 1.46
10549097 Ldhb −1.34 −1.33 −1.17 −1.17
Monocarboxylate transporters and v–H+ ATPase
10495035 Slc16a1 (Mct1) 1.49 1.28 −1.44 1.01
10372988 Slc16a7 (Mct2) −4.07 −4.06 −1.73 −2.42
10383502 Slc16a3 (Mct4) 1.97 2.08 1.74 2.83
10464529 Tcirg1 (Atp6v0a3) 1.54 1.61 −1.01 −1.17
10381187 Atp6v0a1 −2.09 −1.37 −1.78 −2.14
10525804 Atp6v0a2 1.61 1.50 1.56 1.22
Hypoxia-inducible factor and regulation
10396421 Hif1a 1.84 1.94 −1.11 1.58
10447317 Epas1 (Hif2a) −1.31 −1.19 −1.24 −1.07
10560329 Hif3a −1.01 −1.10 1.11 1.13
10463380 Hif1an −1.55 −1.44 −1.08 −1.20
10582712 Egln1 (Phd2) −1.75 −1.19 −1.40 −1.11
10561170 Egln2 (Phd1) 1.49 1.26 1.70 1.36
10400304 Egln3 (Phd3) 1.19 1.21 1.35 2.04
10384725 Rel 3.04 3.22 −1.43 −1.22
10460631 Rela 1.37 1.56 −1.12 −1.18
10560575 Relb 1.90 2.16 1.07 1.13
10502299 Nfkb1 3.38 3.37 −1.25 −1.16
10463599 Nfkb2 2.98 3.34 1.34 1.49
10577560 Ikbkb 1.27 1.18 −1.10 −1.09
The annotated and differentially expressed genes (bolded) were identified based on changes in average expression levels with a significance of P ≤ 0.05 (bolded). The gene 
expression ratios at 6 and 24 h postinfection were compared to the values of uninfected and calculated as median-centered values (from three independent experiments), and 
the log2 expression ratio was converted to fold change. Data were derived from microarray data [Gene Expression Omnibus (GEO) repository accession number GSE31734; 
Koo et al. (77)].
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The warburg effect in the Rabbit 
Model of TB
We have established a rabbit model of pulmonary Mtb infection 
that closely mimics the pathological features of Mtb infection/
disease seen in humans (24, 25, 79, 80). We analyzed the kinetics 
of lung transcriptome of rabbits infected aerogenically by Mtb 
HN878, in which lung pathology shows features of active disease 
with the development of necrotic granulomas and cavities (24). 
The transcriptome analysis clearly showed an upregulation of 
gene networks involved in inflammatory immune response and 
antimicrobial molecules production (24), concurrent with the 
upregulation of genes encoding the Warburg effect enzymes/
isozymes between weeks 4 and 8 postinfection (Figure  2). 
SLC2A4, which encodes the facilitative glucose transporter 
FiGURe 2 | intensity plot of the warburg effect-associated gene 
expression in Mtb HN878-infected rabbit lungs. Microarray data from 
Mtb HN878-infected or uninfected rabbit lungs at 4, 8, and 12 weeks 
postinfection (n = 4 per time point per group) were normalized and analyzed 
using Partek Genomics Suite (PGS) ver 6.5. Data shown are fold change in 
gene expression in the infected, compared to uninfected rabbit lungs. Only 
significantly differentially expressed genes (P ≤ 0.05) are shown in the plot. 
Intensity plot was constructed using Partek Genomics Suite (PGS) ver 6.5. 
The color scale ranges from +3 (up; red) to −3 (down; blue). The genes are 
arranged according to their hierarchical position in respective pathways. Data 
are derived from GEO# GSE27992 and 33094 [Subbian et al. (24)].
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member 4 (GLUT4), was induced in rabbit lungs. GLUT4 is 
implicated in insulin-regulated glucose uptake (81) and is associ-
ated with elevated glycolysis in cancers (82, 83). Moreover, three 
out of the four genes encoding the PFK-2 members, PFKFB2, 
PFKFB3, and PFKFB4, were induced in HN878 infected rabbit 
lungs (Figure 2). As both PFKFB2 and PFKFB4 have much lower 
6-phosphofructo-2-kinase to fructose-2,6-bisphosphatase activ-
ity ratio than PFKFB3 (78, 84), the formation of F-2,6-BP by these 
two enzymes could be very limited (84); thus, their contribution 
to glycolysis is expected to be restricted. In addition, alongside 
the induction of MCT4, SLC16A7 encoding the MCT2, was also 
induced in HN878-infected rabbit lungs. As MCT2 has much 
higher affinity for pyruvate than MCT4 (85), its induction could 
be related to the pyruvate metabolism in mitochondria. Indeed, 
knockdown of MCT2 was shown to result in mitochondrial dys-
function, cell-cycle arrest, and senescence in cancer cells (86). In 
the HN878-infected rabbit lungs, as the disease progresses with 
exacerbated disease pathology, sustained level of high bacillary 
load, and a compromised host immune response at 12  weeks 
postinfection and beyond (24), expression of the Warburg effect 
enzymes/isoenzymes and HIF-1α remained at elevated levels 
(Figure 2). These transcriptome data suggest that progression of 
active disease is also accompanied with an elevated Warburg effect 
in infected rabbit lungs, perhaps driven by the elevated bacillary 
load that can serve as potent antigen to stimulate macrophages 
and lymphocytes. More in-depth studies are needed to under-
stand whether upregulation of different Warburg effect isozymes 
and MCTs contributes to the different immune responses elicited 
by the two Mtb strains in the infected rabbit lungs.
The warburg effect in the Lung 
Granulomas of Patients with Active TB
To extend our observation of the Warburg effect in multiple 
models of TB and its possible association with the host immune 
response during Mtb infection, we analyzed the transcriptome 
data from the cavitary lung granulomas of human patients with 
active TB and compared them to the corresponding profiles from 
uninvolved portions of the same lungs (87). The genome-wide 
transcriptional profiling of the human lung TB granulomas 
revealed significant upregulation of network/pathway genes 
associated with immune cell movement, IL-17-mediated inflam-
matory response, and STAT1-mediated T cell activation (87). 
Moreover, genes involved in vitamin D receptor (VDR) signal-
ing and interferon signaling were upregulated and enriched in 
granulomas with higher bacillary loads relative to uninvolved 
lung tissue (87).
Consistent with our findings in the model systems, a more 
inclusive set of genes encoding the enzymes/isozymes involved in 
the Warburg effect, HIF-1α regulation, and cytosolic pH regula-
tion by H+-ATPase and MCTs were also found in the lung granu-
lomas of patients with active TB (Figure 3). Specifically, multiple 
genes encoding GLUTs, including GLUT1, GLUT3, GLUT5, and 
GLUT6, were upregulated in active TB granulomas. GLUT3 was 
induced to the highest degree among all glucose transporters, 
underscoring its potential role in glucose metabolism during 
active TB in human lungs. Among the glucose phosphorylation 
genes, alongside HK1 and HK3, ADPGK encoding the ADP-
dependent glucose kinase (ADPGK) was also highly upregulated. 
ADPGK is not a target of HIF-1 and does not appear to contribute 
to glycolysis in cell lines and cancer cells (88). However, T cell 
activation was shown to be dependent on ADPGK-driven 
enhanced glucose uptake and glycolysis and linked to mito-
chondrial ROS generation from the activation of respiratory- 
chain-associated glycerol-3-phosphate dehydrogenase 2 (GPD2) 
(89). Downregulation of ADPGK or GPD2 abundance was shown 
to inhibit oxidative signal generation and induction of NF-κB-
dependent gene expression (89). Thus, ADPGK appears to be 
associated with the activation of T cells in the lung granulomas 
of patients with active TB.
FiGURe 3 | expression profile of the warburg effect-associated genes in the lung granulomas of patients with active pulmonary TB. Microarray 
data from granulomas or uninvolved lung areas were normalized, analyzed and plotted using Partek Genomics Suite (PGS) ver 6.5. Data shown are fold 
change in gene expression in the lung granulomas, compared to uninvolved lungs of pulmonary TB patients. Only significantly differentially expressed genes 
(P ≤ 0.05) are shown in the plot. The genes are arranged according to their hierarchical position in respective pathways. Data are derived from GEO# 
GSE20050 [Subbian et al. (87)].
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Consistent with the observations in murine models, active 
TB in human lungs is also concurrent with a heightened 
induction of PFKFB3, encoding the key enzyme potentiating 
glycolytic flux through activating PFK-1 enzymes. The concur-
rent high induction of PFKM encoding PFK-M isoform of 
PFK-1 suggests its potential role in the glycolytic flux in the 
human lung granulomas. Moreover, alongside the induction of 
MCT4, SLC16A1  encoding MCT1 was also upregulated in the 
granulomas of active TB patients, consistent with its ubiquitous 
expression in multiple types of primary cells and cell lines (90, 
91). As MCT1 also functions in lactate uptake (90), its upregula-
tion may also indicate increased lactate metabolism in the lung 
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granulomas of active TB patients. In addition, the heightened 
induction of H+-ATPase involved in cytosolic pH homeostasis, 
as seen in mouse lungs (71), is also in agreement with increased 
expression of glycolysis genes in the lung granulomas of active 
TB patients (Figure 3). In accordance with the expression profile 
of the Warburg effect and immune activation network genes, 
immune cell profiling of these active TB granulomas showed 
higher numbers of CD3+/CD4+ T cells as well as CD68+ mac-
rophages and multinucleated giant (MNG) cells relative to those 
in uninvolved lungs (87). Thus, our data strongly suggest a posi-
tive correlation between the Warburg effect and host immune 
response specifically in the granulomatous microenvironment, 
which is distinct from the uninvolved lung tissue adjacent to the 
granulomas. Understanding of how a change in the Warburg 
effect is associated with disease progression and/or therapeutic 
treatment can be harnessed to develop novel and effective thera-
peutic agents for TB treatment.
SiGNALiNG PATHwAYS AND HOST 
FACTORS ASSOCiATeD wiTH THe 
wARBURG eFFeCT DURiNG  
Mtb iNFeCTiON
Multiple mechanisms have been reported to contribute to the 
increased HIF-1α expression and the Warburg effect during Mtb 
infection. NF-κB family proteins are the primary transcriptional 
regulatory factors involved in initiating/maintaining cellular 
response during host innate and adaptive immunity (92). These 
proteins regulate the transcription of various cytokine/chemokine 
genes as well as those involved in intracellular signaling, whose 
products are not only essential components of the immune 
response (92) but also crucial for the transcriptional activation 
of Hif-1a/HIF-1A (57, 63, 93). During Mtb infection, expression 
of the NF-κB family members was upregulated in macrophages, 
mouse and rabbit lungs, as well as in the granulomas of human 
pulmonary TB patients (71, 87) (Table 1; Figures 1–3). For the 
activation of NF-κB, IkappaB kinases (IKK), especially IKK-β, 
are required for the phosphorylation-induced degradation of 
NF-κB inhibitors in response to infection and inflammation, and 
IKK-β is also essential for HIF-1α accumulation in macrophages 
during bacterial infection (57). NF-κB proteins then dimerize 
and translocate into the nucleus to activate the transcription of 
Hif-1α/HIF-1A and other target genes (92). In agreement with 
these findings, we observed upregulation of Ikbkb/IKBKB during 
Mtb infection in murine MBDMs as well as in the lungs of mice 
and rabbits and in the lung granulomas of pulmonary active TB 
patients (24, 71, 87).
Another pathway of NF-κB signaling activation was shown 
to be associated with the induction of ROS from mitochondrial 
electron transport chain (mROS) due to the downregulation 
of oxidative phosphorylation (94). This process was associated 
with TLR-1-, -2-, and -4-mediated signaling that promotes and 
translocates the TNF-associated factor 6 (TRAF6) to mitochon-
dria to potentiate mROS generation through evolutionarily 
conserved signaling intermediate in toll (ECSIT) pathways (94). 
The requirement for ECSIT and/or TRAF6 for mROS production 
was shown in Salmonella typhimurium-infected macrophages 
where a reduction in TLR-induced ROS impaired the ability of 
murine macrophages to kill the bacteria (94). Interestingly, Mtb 
infection also induced the expression of both ECSIT and TRAF6 
in murine macrophages and in the lungs of infected mice and rab-
bits as well as in the granulomas of human pulmonary TB patients 
(23, 24, 77, 87). However, the direct contribution of mROS to the 
antimicrobial immune response against Mtb and to the Warburg 
effect remains to be elucidated.
Several host factors contribute to the elevated expression of 
HIF-1α and the associated immune/metabolic responses dur-
ing Mtb infection in  vitro and in  vivo. One such factor is NO, 
which is generated by the action of an inducible NO synthase 
(NOS2/iNOS) in infected murine macrophages and in the lungs 
of infected mice and rabbits (24, 77, 95). As a target of HIF-1α 
(60, 96), NOS2/iNOS induction may result in the redistribution 
of intracellular oxygen and inhibition of the PHDs, the negative 
regulators of HIF-1α (97), thus forming a positive feedback 
loop that leads to a sustained high level of HIF-1α and amplifies 
macrophage activation. Second, increased level of TCA cycle 
intermediate succinate in Mtb-infected mouse lungs (72) can 
elevate the level of HIF-1α by inhibiting the activity of PHDs 
(32). Third, decreased levels and/or functions of PHD1 and 2 
due to the reduced transcription of these enzymes reported in 
Mtb-infected mouse lungs and active human TB lung granulomas 
(71, 87) (Figures 1 and 3) can contribute to the elevated levels 
of HIF-1α. Fourth, downregulation of Hif-2a/HIF-2A, encoding 
another oxygen-responsive component of the HIF family, can 
also indirectly enhance the level and/or function of HIF-1α dur-
ing Mtb infection. Indeed, we have observed downregulation of 
Hif-2a/HIF-2A in Mtb-infected murine macrophages and mouse 
lungs as well as in the lung granulomas of active TB patients (71, 
77, 87) (Figures 1 and 3; Table 1).
Hypoxia-inducible factor 2 alpha has physiologically 
antagonistic functions with HIF-1α (98), and its transcription is 
induced by Th2 cytokines and is associated with M2 macrophage 
polarization (98). Moreover, as HIF-2α also regulates the expres-
sion of ARG1, which competes with NOS2/iNOS for arginine, 
a common substrate for both enzymes (98), downregulation of 
HIF-2α indirectly favors M1 macrophage polarization by tipping 
the balance toward enhanced HIF-1α-mediated Warburg effect 
and the antimicrobial function against Mtb. Downregulation of 
HIF-2α can be related to the upregulation of phd3/PHD3 during 
Mtb infection. In contrast to phd1 and phd2, the expression of 
phd3 was increased in Mtb-infected mouse lungs (71), consistent 
with the presence of a hypoxia-responsive enhancer element 
in phd3 (99). In addition, expression of phd3/PHD3 was also 
upregulated in Mtb-infected MBDMs and rabbit lungs (Table 1; 
Figure 2). Interestingly, because PHD3 best retains its function 
under prolonged hypoxia, compared to the other two paralogs, 
PHD1 and PHD2 (100), and exhibits a higher activity toward 
HIF-2α (101), its upregulation during Mtb infection can lead 
to specific degradation of HIF-2α. Thus, the divergent expres-
sion and regulation of HIF-1α and HIF-2α in response to Mtb 
infection suggests a synergy in activated host immune cells to 
maximize HIF-1α-mediated host antimicrobial and inflam-
matory response. Indeed, an inverse correlation between the 
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bactericidal activity and the HIF-2α expression has been reported 
in activated neutrophils (75).
Enhanced HIF-1α expression and its roles in the regulation of 
the Warburg effect and antimicrobial response during Mtb infec-
tion of host immune cells have also been shown to be associated 
with the function of pyruvate kinase M2 (PKM2), a key metabolic 
regulator for glycolysis (102). Expression of PKM2, one of the 
two Pkm/PKM products, is upregulated during macrophage 
activation, while the cytosolic PKM1 that performs its catalytic 
function as a tetramer shows little change (102). In the cyto-
plasm, PKM2 exists primarily in an enzymatically inactive state 
by phosphorylation, and its dimer translocates into the nucleus, 
where it interacts with HIF-1α to activate target genes, including 
those encoding glycolytic enzymes and IL-1β (102). However, 
in activated macrophages, PKM2 activation by small molecules, 
such as TEPP-46, leads to the formation of a tetrameric structure 
that prevents its translocation into the nucleus, resulting in 
diminished Warburg effect and IL-1β production. This process 
also boosts the production of immune suppressive cytokine IL-10 
and a decreased antimicrobial response, as observed against S. 
typhimurinum infection (102). In our studies, upregulation of 
Pkm2/PKM2 in Mtb-infected murine macrophages, mouse and 
rabbit lungs as well as in the granulomas of human pulmonary 
TB patients (71) (Figures 1–3; Table 1) suggests that PKM2 has 
a similar regulatory role in facilitating the induction of HIF-
1α-mediated Warburg effect and the associated antimicrobial 
response during Mtb infection. Finally, PHD3 has been shown to 
enhance glucose uptake and lactate production by facilitating the 
binding of PKM2 to HIF-1α, which activates HIF-1α-mediated 
gene expression (103).
In summary, it appears that the host immune cells mount 
a coordinated molecular signaling program to maximize the 
antimicrobial response during Mtb infection by integrating 
multiple mechanisms that lead to the induction of HIF-1α and 
the associated Warburg effect cascade. However, whether these 
mechanisms regulate cellular metabolism in different types/sub-
types of immune cells during Mtb infection, how these regulatory 
mechanisms are integrated, and how they evolve during different 
stages of TB remain to be elucidated.
PeRTURBiNG THe wARBURG eFFeCT AS 
A MeCHANiSM OF Mtb PATHOGeNiCiTY?
A Hypothesis
A switch in the bioenergetics from oxidative phosphorylation to 
the Warburg effect promotes M1 macrophage polarization that 
activates a Th1 adaptive response (16), both of which contribute 
to effective host defense against pathogens. However, the ability 
of Mtb to replicate and persist within the host cell suggests a 
novel survival mechanism, whereby the infecting Mtb perturbs 
the Warburg effect of host immune cells to dampen the M1 
macrophage polarization. Similarly, interference of the metabolic 
switch in Mtb-infected DCs can also dampen their maturation 
and function. Modulation of the metabolic state in these antigen-
presenting cells (APCs) by Mtb would thus diminish their ability 
to express MHC-II molecules and present antigens to CD4+ and 
CD8+ T cells, compromising activation, proliferation, and func-
tions of the Th1 cellular response, which in turn would change 
M1/M2 polarization balance to favor the survival and persistence 
of the pathogen.
Multiple lines of evidence support our hypothesis presented 
above, including our observations from in vitro and in vivo stud-
ies of Mtb infection and from the lung granulomas of active TB 
patients. Alongside the expression of pro-inflammatory cytokine/
chemokine and antimicrobial effector molecules, such as NOS2/
iNOS, IL-12, and IL-1β, the concurrent induction of immune 
repressive IL-10 and ARG1 in Mtb-infected macrophages, lungs 
of mice and rabbits, and in the lung granulomas of active TB 
patients, suggests a suboptimal macrophage activation (24, 71, 
77, 87, 104–106). Indeed, macrophage-derived IL-10 was shown 
to induce alternatively activated macrophages and promote exac-
erbation of chronic Mtb infection (105). A delayed Th1 immunity 
in pulmonary Mtb infection has been shown to be associated with 
the activation of immunoadaptor DAP-12-regulated IRAK-M 
and increased IL-10 expression in APCs (12). In addition, the 
differential expression of ARG1 in lungs of rabbits infected by 
Mtb CDC 1551 and HN878 can be a contributing factor to the 
different infection outcome by the two strains. Indeed, ARG1 was 
dampened early during Mtb CDC1551 infection of the rabbit 
lungs that ultimately develops latency, while ARG1 expression 
was upregulated in the lungs of rabbits with active TB, which is 
associated with failed immune response (24, 25).
More importantly, our hypothesis is further supported by the 
spatial differential expression of the Warburg effect-associated 
metabolic markers and HIF-1α in macrophages at different loca-
tions within mouse lung granulomas (Figure 4). Macrophages at 
the center of the granuloma, especially those infected with Mtb, 
showed significantly lower Warburg effect, as reflected by reduced 
expression of LDHA and H+-ATPase, compared to those in the 
periphery. In contrast, HIF-1α expression and glucose metabo-
lism, as defined by increased expression of HK3, were higher in 
macrophages at the center of the granulomas than in those at the 
periphery (Figure 4). A reduced Warburg effect in the presence of 
high glucose metabolism in macrophages at the center of granu-
lomas strongly suggests that Mtb perturbs the Warburg effect by 
siphoning off carbon flux, which should diminish the Warburg 
effect and hence result in suboptimal activation and functional-
ity of infected macrophages. This notion is consistent with the 
findings that virulent Mtb strains induce more glucose uptake 
and perturb the glycolytic pathway of host cells, causing them 
to differentiate into foamy macrophage phenotype, compared to 
avirulent strains (107). Based on our observations, it is reasonable 
to suggest that therapeutic compounds that have the potential to 
enhance the Warburg effect in host immune cells, particularly 
in Mtb-infected macrophages, can be identified, developed, and 
used as anti-TB therapy.
In addition to TB, a deregulated immunometabolism has been 
found to be associated with pathogenicy of others pathogens, 
including HIV-1 (108–110). For example, in HIV-1-infected pri-
mary CD4+ T cells, a highly induced glycolytic capacity coupled 
with hyperreactive pro-inflammatory response was found to be 
essential for virion production (111, 112). Interestingly, in HIV-
1-infected macrophages, the viral reservoirs, HIV-1 infection 
FiGURe 4 | Differential expression of HiF-1α, HK3, LDHA, and ATP6a3 of H+-ATPase in macrophages of infected mouse lung granulomas. 
Immunohistochemical staining, confocal imaging, 3D reconstruction, and analysis were carried out using 20 μm lung tissue sections obtained from uninfected 
control and Mtb-infected C57BL/6 mice at day 30 postinfection. Tissue sections were stained for nuclei (DAPI), Mtb, target proteins, and macrophages (IBA-1). The 
expression of target protein was obtained by measuring the positive pixels and their intensities from equal number of cells of the specific regions of interests (ROIs) 
from the 3D reconstruction. Differential expression of target proteins relative to uninfected controls was carried out in macrophages at the center (within 20 μm in 
diameter) of granulomtous lesions with or without Mtb and in peripheral macrophages (20–40 μm in diameter). Three sections per lung region were examined for 
each animal and four animals were analyzed. Data shown are means ± SDs of the measurement from four mice. ** indicates P ≤ 0.005 between values obtained in 
macrophages at the center of granulomas in comparison to those at the peripheral areas. Data are from Shi et al. (71). Abbreviation: AU, arbitrary units.
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downregulates the Warburg effect by hijacking the metabolic 
function of HK1, thus conferring a survival advantage of host 
cell for the long-term viral persistence (113, 114).
Roles of Mtb eSAT-6/CFP-10 in the 
Regulation of Host immune Response 
and Cellular Metabolism
The different degree of virulence between Mtb CDC1551 
and HN878 has been attributed to the presence of a phenolic 
glycolipid (PGL), a surface lipid of the complex Mtb cell wall 
that enhances virulence by increasing the infectivity of clinical 
Mtb isolates, especially in the W-Beijing strains (115). However, 
increasing evidence also suggests that Mtb ESAT-6/CFP-10 
complex, one of the primary virulence factors of pathogenic 
strains, plays an important role in regulating host metabolism 
and immune response during Mtb infection. ESAT-6 and CFP-10 
are two low molecular weight secreted proteins encoded by the 
region of difference 1 (RD1) of the Mtb genome (116). RD1 is 
absent in all vaccine strains of avirulent M. bovis BCG but is 
present in the virulent laboratory and clinical strains of M. bovis 
and Mtb (117). Findings from multiple studies also suggest that 
the ESAT-6/CFP-10 complex contributes to Mtb virulence by 
deactivating macrophage, dendritic, and T cell functions (118). 
Supporting evidence includes the requirement of ESAT-6/CFP-
10 for Mtb replication and pathogenesis in vivo and the attenu-
ated phenotype of Mtb mutants with no ESAT-6 production and/
or secretion, including Mtb Ra, ΔRD-1, Δesat-6, ΔphoP, and 
Δsnm (119–122).
Functionally, ESAT-6 has been shown to inhibit host cell 
TLR-signaling by directly binding to TLR2, resulting in reduced 
secretion of IL-12 p40 and TNF in macrophages (123). In addi-
tion, ESAT-6 was shown to be secreted into the cytosol of infected 
macrophages (124) and to induce the production of type I IFN 
(119, 125). Moreover, Mtb mutants, without RD1 or esat-6, 
induce more robust pro-inflammatory cytokines in infected 
murine macrophages (119). In addition, exogenous ESAT-6 
was found to induce host cell glucose uptake and perturbation 
of host cell glycolytic flux similar to that caused by virulent Mtb 
strains, leading to formation of the foamy macrophage phenotype 
in host cells (107, 126). These observations suggest that the role 
of ESAT-6/CFP-10 in dampening the pro-inflammatory and 
FiGURe 5 | Schematic representation of HiF-1 regulation and the warburg effect in TB. (A). Key factors/steps leading to HIF-1 activation in response to 
Mtb infection. Blue block line indicates blockade and broken arrow shows indirect interaction. (B). Upregulation of the Warburg effect state with effective M1 
macrophage activation and efficient Th1 immunity, both of which lead to efficient Mtb clearance. (C). Downregulation of the Warburg effect with compromised M1 
macrophage polarization and dampened Th1 response that results in poor elimination of Mtb and promotes Mtb persistence. For (A–C), red color (arrows and fill-in) 
indicates activation/upregulation and blue color denotes suppression/downregulation.
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antimicrobial responses of immune cells is associated with their 
ability to interfere with the metabolic state of respective host 
cells. The interference of host metabolism by ESAT-6/CFP-10 
is underscored by a recent report showing that ESAT-6/CFP-10 
interacts directly with the host cell glycolytic enzymes ENO1 and 
PGK1, leading to the perturbation of glycolytic flux (126). It will 
be interesting to test whether the Warburg effect is enhanced in 
host cells infected by Mtb mutant strains with diminished ability 
to express and/or secrete ESAT-6 in comparison with wild-type 
and complemented strains.
CONCLUSiON
Activation of the Warburg effect in host immune cells in response 
to Mtb infection reveals a novel link between metabolic remod-
eling and host immune response, including the expression of 
antimicrobial and inflammatory immune responses. We postulate 
that the ability of pathogenic Mtb to compromise host bactericidal 
machinery by interfering with the metabolic switch to the Warburg 
effect can be a novel adaptation strategy for Mtb persistence and 
pathogenicity (Figure 5). Therefore, it is worth investigating the 
correlation between the macrophage polarization states, activa-
tion and differentiation of various T cell types/subtypes, and their 
bioenergetic pathways at different stages of Mtb infection. We 
anticipate that the evolving microenvironment within the granu-
lomas regulates not only the immune response but also the local 
bioenergetic state. It is also important to define the correlation 
between the immune response and the Warburg effect in relation 
to the spatial localization of immune cells within different types of 
lung granulomas. A better understanding of immunometabolism 
in TB will provide promising avenue(s) for the development of 
novel therapeutic strategies that target the host cell metabolism to 
enhance antimicrobial and pro-inflammatory functions.
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